Members |
targetComponentId |
levofloxacin 25 mg/ml oral opløsning |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
levofloxacin 5 mg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
Levofloxacin 5 mg/mL solution for injection |
levofloxacin 5mg/ml oftalmisk opløsning |
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
Levoleucovorin calcium 50mg powder for injection solution vial |
Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial |
levomethadylacetathydrochlorid 10 mg/ml oral opløsning |
Levomethadyl 10 mg/mL oral solution |
levonorgestrel 0,015 mg/dag + estradiol 0,045 mg/dag transdermalt system |
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
levonorgestrel 52 mg, intrauterint system |
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) |
Levothyroxine sodium 0.05mg tablet |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
Levothyroxine sodium 0.075mg tablet |
Levothyroxine sodium anhydrous 75 microgram oral tablet |
Levothyroxine sodium 0.1mg tablet |
Levothyroxine sodium anhydrous 100 microgram oral tablet |
Levothyroxine sodium 200mg tablet |
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug) |
Levothyroxine sodium o.05mg |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
Leydig cell neoplasm of testis |
Leydig cell tumor of testis of uncertain behavior |
Leydigs tumor |
Leydig cell tumor of uncertain behavior (morphologic abnormality) |
Librarian/info.officer NOS |
Librarian/information officer |
Librarian/information officer NOS (occupation) |
Librarian/information officer |
Lichen NOS |
Lichen |
Lichen NOS |
Lichen |
Lichen sclerosus et atrophicus |
Lichen sclerosus |
Kraurosis vulvae |
Lichen sclerosus of vulva (disorder) |
Lichen sclerosus et atrophicus, bulløs type |
Lichen sclerosus bullous type (disorder) |
Liddle's syndrome |
Pseudoprimary hyperaldosteronism (disorder) |
lidocain 1 %/adrenalin 1 til 200.000 injektionsvæske, hætteglas a 20 ml |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
lidocain 1,5 % injektionsvæske, opløsning, hætteglas |
Lidocaine only product in parenteral dose form |
lidocain 2 %/adrenalin 1 til 200.000 injektionsvæske, 20 ml hætteglas |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocain 2,5 % salve til topikal anvendelse |
Lidocaine hydrochloride 25 mg/g cutaneous ointment |
lidocain 2,5 %/prilocain 2,5 % periodontalgel |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
lidocainhydrochlorid 0,1 %/glucose 5 % infusionsvæske, opløsning, pose |
Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocainhydrochlorid 0,2 %/glucose 5 % infusionsvæske, opløsning, pose |
Lidocaine hydrochloride 2 mg/mL solution for injection |
lidocainhydrochlorid 0,4 %/glucose 5 % infusionsvæske, opløsning, pose |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, ampul |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 0,5 % injektionsvæske, opløsning, hætteglas |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 0,6 % + glucose 5 % infusionsvæske, opløsning, pose |
Product containing precisely lidocaine hydrochloride 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Lidocaine hydrochloride 1% conventional release solution for injection ampule |
Lidocaine only product in parenteral dose form |
Lidocaine hydrochloride 1% injection |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocainhydrochlorid 1 % injektionsvæske, opløsning, ampul |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 1 % steril injektionsvæske, opløsning, ampul |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocainhydrochlorid 1 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
lidocainhydrochlorid 1 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
lidocainhydrochlorid 1,5 % injektionsvæske, opløsning, ampul |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 1,5 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
lidocainhydrochlorid 10 %/adrenalin 0,1 % iontoforetisk plaster til topikal anvendelse |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
Lidocaine hydrochloride 2% injection |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 2 % injektionsvæske, opløsning, 5 ml ampul |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocainhydrochlorid 2 % injektionsvæske, opløsning, ampul |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 2 % injektionsvæske, opløsning, hætteglas |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocainhydrochlorid 2 %/adrenalin 1:100.000 injektionsvæske, opløsning, hætteglas |
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocainhydrochlorid 2 %/adrenalin 1:200.000 injektionsvæske, opløsning, hætteglas |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
lidocainhydrochlorid 2 %/adrenalin 1:500.000 injektionsvæske, opløsning, hætteglas |
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
lidocainhydrochlorid 4 % injektionsvæske, opløsning, ampul |
Lidocaine hydrochloride 40 mg/mL solution for injection |
Lidocaine hydrochloride 5% injection solution |
Lidocaine only product in parenteral dose form |
lidocainhydrochlorid 5 %/glucose 7,5 % injektionsvæske, opløsning, hætteglas |
Lidocaine hydrochloride 50 mg/mL solution for injection |
lidocainhydrochlorid + adrenalin 0,5 %/1:200.000 injektionsvæske |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Lidocaine hydrochloride+epinephrine 1%/1:100,000 injection |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
lidocainhydrochlorid + adrenalin 2 %/1:80.000 cylinderampul |
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Lidocaine hydrochloride+epinephrine 4% conventional release nasal drops |
Adrenaline and lidocaine only product |
lidocainhydrochlorid + adrenalin 4 % næsedråber uden konserveringsmiddel |
Adrenaline and lidocaine only product |
Lidocaine hydrochloride+fluorescein sodium 4%/0.25% conventional release eye drops |
Fluorescein stain and lidocaine only product |
lidokainhydrochlorid 4 % + fluoresceinnatrium 0,25 % øjendråber til engangsbrug |
Fluorescein stain and lidocaine only product |
ideatorisk apraksi |
Transcortical apraxia |
Life assurance examination NOS |
Life assurance - examination |
Life assurance examination NOS |
Life assurance - examination |
Life assurance preliminary report NOS |
Life assurance report status |
Life assurance preliminary report NOS |
Life assurance - preliminary report |
Life circumstance problem |
Social and personal history finding |
Life crisis NOS |
Life crisis, life event (finding) |
Livskrise, ikke nærmere specificeret |
Life crisis, life event (finding) |
Livslang psykisk forstyrrelse |
Chronic mental disorder |
Ligation of fallopian tube with crushing |
Ligation and crushing of bilateral fallopian tubes (procedure) |
Ligation of organ NOC |
To bind with a ligature |
Light laborer NOS |
Labourer |
Light labourer NOS |
Labourer |
lignocain 5 % + hydrocortisonacetat 0,275 % salve |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
Lignocaine hydrochloride 1% injection(plastic amp) |
Lidocaine only product in parenteral dose form |
Lignocaine hydrochloride+adrenaline 2%/1:200000 sterile wrapped injection |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
Lignocaine hydrochloride+glucose 5%/7.5% injection |
Lidocaine hydrochloride 50 mg/mL solution for injection |
Lincomycin 300mg/mL injection |
Lincomycin only product in parenteral dose form |
allergi over for lincomycin og derivater deraf |
Allergy to drug |
lincomycinhydrochlorid 300 mg/ml injektionsvæske, opløsning, ampul |
Lincomycin only product in parenteral dose form |
Linezolid 100mg/5mL granules for oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
linezolid 100 mg/5 ml granulat til oral suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Linezolid 100mg/5mL suspension |
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
linezolid 2 mg/ml infusionsvæske, opløsning, pose a 300 ml |
Product containing precisely linezolid 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Liothyronine sodium preparation |
Product containing liothyronine (medicinal product) |
fund vedr. læbe og mundhule udtrykt ved TNM-systemet |
American Joint Committee on Cancer allowable value |
Lip flap |
Flap (substance) |
Røntgenundersøgelse af bløddel i læbe |
Plain X-ray of lip (procedure) |
Lipoma of spinal column |
Lipoma of spinal cord |
Lipoprotein electroph. NOS |
Lipoprotein electrophoresis |
Lipoprotein electroph. NOS |
Lipoprotein electrophoresis |
Liposarkom |
Liposarcoma |
Liposomal daunorubicin 2mg/mL injection emulsion |
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) |
liposomalt doxorubicinhydrochlorid 2 mg/ml koncentrat til infusionsvæske, hætteglas a 10 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
liposomalt doxorubicinhydrochlorid 2 mg/ml koncentrat til infusionsvæske, hætteglas a 25 ml |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Liposuction of subcutaneous tissue NEC |
Liposuction of subcutaneous tissue |
Liquid paraffin [eye] |
Product containing mineral oil (medicinal product) |
Liquid paraffin [laxative] |
Product containing mineral oil (medicinal product) |
Liraglutide 6mg/mL injection solution |
Product containing only liraglutide (medicinal product) |
allergi over for lisinopril |
Non-allergic hypersensitivity to lisinopril |
Listed for hosp admission NOS |
Listed for admission to hospital |